Pemafibrate is under investigation in clinical trial NCT03350165 (A Study of Pemafibrate in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.